Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN1117746C details a high-yield iron-catalyzed process for substituted pyridines, offering cost-effective routes for endothelin receptor inhibitors.
Patent CN105693627A reveals efficient Ru-pheox catalysis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Patent CN1213029C details a robust synthesis for 5-HT2A antagonists. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
High-purity Ketanserin preparation via improved condensation and recrystallization. Cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Patent CN104193674B details a low-temperature phase-transfer catalytic route for flunixin meglumine, offering enhanced purity and streamlined manufacturing for veterinary pharmaceutical supply chains.
Novel debenzylation and alkylation process for tachykinin antagonist intermediates offering high yield and supply chain stability.
Patent CN108191778A reveals one pot synthesis reducing costs. Enhances supply chain reliability for high purity pharmaceutical intermediates manufacturing globally.
Patent CN107286078A details a safer pimavanserin route using triphosgene. This method ensures high purity and scalable production for reliable pharmaceutical intermediate supply chains.
Patent CN112795606A reveals a novel PNP/NRK enzymatic route for NMN. Achieve superior conversion rates and cost efficiency in pharmaceutical intermediate manufacturing.
Novel synthesis of 4'-hydroxy-4,6'-dimethoxydihydrochalcone via Pd/C hydrogenation offers high purity and scalable pharmaceutical intermediate production.
Novel low-temperature catalytic method enhances purity and yield for pitavastatin calcium intermediate manufacturing ensuring reliable supply chain and cost efficiency.
Advanced purification method for Glimepiride achieving >99.9% purity. Optimized solvent systems reduce impurities and ensure scalable manufacturing for diabetes medication supply chains.
Patent CN101260092B details a cost-effective, water-based synthesis for Cinepazide Maleate, offering high purity and stable crystal forms for cardiovascular drug manufacturing.
Patent CN103044345B offers a two-step synthesis for Flomoxef intermediate with high yield and purity, reducing cost and waste for reliable supply chains.
Patent CN110004119B discloses a thermostable epsilon-ketoester reductase mutant enabling efficient synthesis of (R)-alpha-lipoic acid precursors with reduced catalyst loading and enhanced stability.
Novel synthetic route for Zofenopril Calcium offering high purity and scalable production for global pharmaceutical supply chains and cost reduction.
Patent CN120247907A details improved synthesis for IAP antagonist intermediate (XXIII). Enhanced purity, stability, and supply chain reliability for pharmaceutical manufacturing.
Patent CN111484424B reveals a copper-catalyzed route for omacycline intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN104327073B details a safer semi-synthetic route for Vinpocetine, eliminating column chromatography to ensure high purity and cost reduction in API manufacturing.
Patent CN111172124A reveals a novel carbonyl reductase mutant enabling high-concentration synthesis. Discover cost-effective supply chain solutions for this key pharma intermediate.